KIRBY, 2014 - Google Patents
EARL W. DAVIEKIRBY, 2014
- Document ID
- 200199448131731898
- Author
- KIRBY E
- Publication year
- Publication venue
- Current Topics in Cellular Regulation
External Links
Snippet
EARL W. DAVIE Page 72 Molecular Mechanisms in Blood Coagulation' EARL W. DAVIE *
Department of Biochemistry University of Washington Seattle, Washington EDWARD P. KIRBY
Department of Biochemistry Temple University School of Medicine Philadelphia, Pennsylvania …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Davie et al. | The coagulation cascade: initiation, maintenance, and regulation | |
| Stocker et al. | Thrombin-like snake venom proteinases | |
| Kornalik | Toxins affecting blood coagulation and fibrinolysis | |
| AU607303B2 (en) | Composition of anticoagulants | |
| US9493761B2 (en) | Procoagulant molecular decoy for treating hemophilia A or B with or without inhibitor | |
| Dahlback | Factor V and protein S as cofactors to activated protein C | |
| Henriksen et al. | Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382 | |
| Lundblad et al. | The activation of Stuart factor (factor X) by activated antihemophilic factor (activated factor VIII) | |
| EP0785799A1 (en) | Process for production of inhibited forms of activated blood factors | |
| Esnouf | Biochemistry of blood coagulation | |
| AU778571B2 (en) | Factor X analog with an improved ability to be activated | |
| Pentapharm | Thrombin-like snake venom enzymes | |
| US6706512B2 (en) | Antithrombotic thrombin variants | |
| DAVIE et al. | Molecular mechanisms in blood coagulation | |
| Murano | Plasma protein function in hemostasis | |
| Mann | Thrombosis: theoretical considerations | |
| Yang et al. | Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa | |
| Wolf et al. | Design of constructs for the expression of biologically active recombinant human factors X and Xa. Kinetic analysis of the expressed proteins | |
| HUT74873A (en) | Factor vii-derived peptides | |
| Bennett et al. | The normal coagulation mechanism | |
| Pechet et al. | The effect of certain proteolytic enzymes on the thrombin-fibrinogen interaction | |
| JP2001501803A (en) | Hybrid factor VIII with altered activity | |
| KIRBY | EARL W. DAVIE | |
| US5510248A (en) | Stable recombinant meizothrombin-like polypeptides | |
| US5804181A (en) | Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders |